Immunotherapy Committee (ITH)

What is the ITH?

The mission of IUIS Immunotherapy Committee (ITH) is to enhance global health and advance biomedical science by promoting equitable access to comprehensive immunotherapy education, facilitating the dissemination of cutting-edge scientific knowledge and supporting the translation of immunological research into clinical applications.
The ITH Committee aims to foster international collaboration, reduce global disparities in access to and expertise in immunotherapy, and drive innovation in the development and implementation of immunotherapeutic strategies across varied healthcare settings.

To learn more about this committee, please read its Terms of Reference.


Resources

Listen to a BBC5 radio interview on T-cell related discoveries:
http://www.thenakedscientists.com/HTML/specials/show/20160224/

Resources

27Mar2025
IUIS Immunotherapy Committee presents: Harnessing the TME to Enhance the Classification of Tumors
Thursday 27th March 2025Immunotherapy Committee (ITH)

This webinar will discuss groundbreaking advancements in immune mapping of human tumor lesions, providing insights…


Back to Committees

More Committees

Early Career Committee (ECC)

Veterinary Immunology Committee (VIC)

Vaccine Committee (VAC)

Quality Assessment and Standardization Committee (QAS)

Publications Committee (PUB)

Nomenclature Committee (NOM)

Inborn Errors of Immunity Committee (IEI)

Gender Equity Committee (GEC)

Education Committee (EDU)